| Infliximab | Remicade® (Centocor Ortho Biotech Inc.) | For reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy | Daily Med
|